Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.
about
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of DiabetesOne-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trialEfficacy and safety of biphasic insulin aspart and biphasic insulin lispro mix in patients with type 2 diabetes: A review of the literatureInsulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analoguesUsing insulin in type 2 diabetes: in need of a renaissance?Intensification of insulin therapy in patients with type 2 diabetes mellitus: an algorithm for basal-bolus therapyCommon standards of basal insulin titration in type 2 diabetesInitiation and Intensification Strategies in Type 2 Diabetes Management: A Comparison of Basal Plus and Premix RegimensSafety and efficacy of insulin glargine 300 u/mL compared with other basal insulin therapies in patients with type 2 diabetes mellitus: a network meta-analysisPhysicians' perceptions of a national consensus guideline on insulin therapy: Data from the IMPACT studyChallenges associated with insulin therapy progression among patients with type 2 diabetes: Latin American MOSAIc study baseline dataOptimizing display, analysis, interpretation and utility of self-monitoring of blood glucose (SMBG) data for management of patients with diabetes.Comparative efficacy and safety of long-acting insulin analogs in patients with type 2 diabetes failing on oral therapy: Systemic review and meta-analysesEvidence-based clinical use of insulin premixturesAn exploratory trial of insulin initiation and titration among patients with type 2 diabetes in the primary care setting with retrospective continuous glucose monitoring as an adjunct: INITIATION study protocolConcomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetesEfficacy and safety of premixed insulin analogs in Asian patients with type 2 diabetes: A systematic reviewRelationship of baseline HbA1c, HbA1c change and HbA1c target of < 7% with insulin analogues in type 2 diabetes: a meta-analysis of randomised controlled trials.Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysisAn animal model of spontaneous metabolic syndrome: Nile grass ratSwitching from basal or basal-bolus insulin to biphasic insulin aspart 30: Results from the Indian cohort of the A1 chieve studyEvaluation of insulin regimens as an effective option for glycemic control in patients with type 2 diabetes: A propensity score-matched cohort study across Japan (JDDM31)Insulin glargine in the management of diabetes mellitus: an evidence-based assessment of its clinical efficacy and economic value.The DURAbility of Basal versus Lispro mix 75/25 insulin Efficacy (DURABLE) trial: comparing the durability of lispro mix 75/25 and glargineEfficacy of insulin analogs in achieving the hemoglobin A1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials.A propensity score matched comparison of different insulin regimens 1 year after beginning insulin in people with type 2 diabetesTreat-to-target trials: uses, interpretation and review of concepts.A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study.Safety and adverse effects associated with GLP-1 analogues.Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes.Improvements in quality of life associated with biphasic insulin aspart 30 in type 2 diabetes patients in China: results from the A1chieve® observational studyEffectiveness and safety of Humalog Mix 50/50 versus Humalog Mix 75/25 in Chinese patients with type 2 diabetesDiabetes: glycaemic control in type 2 (drug treatments).Role of premixed insulin analogues in the treatment of patients with type 2 diabetes mellitus: a narrative reviewManagement of hyperglycemia in geriatric patients with diabetes mellitus: South Asian consensus guidelines.A randomized, open-label, comparative crossover handling trial between two durable pens in patients with type 1 or 2 diabetes mellitus.Examining correlates of treatment satisfaction for injectable insulin in type 2 diabetes: lessons learned from a clinical trial comparing biphasic and basal analoguesEffects of exenatide twice daily versus sitagliptin on 24-h glucose, glucoregulatory and hormonal measures: a randomized, double-blind, crossover study.The impact of initiating biphasic human insulin 30 therapy in type 2 diabetes patients after failure of oral antidiabetes drugs.Initiating insulin in patients with type 2 diabetes.
P2860
Q24642503-82238C74-6C8E-4C33-8C49-8E0DD6DF6E50Q24656644-5C5A9035-9072-4981-B3B8-1C586A335252Q26749095-0AE92099-6ACD-4F7B-8DCE-59F1C0AF6C5FQ26861313-EADCF629-AE2A-4B5B-A2FF-45E81B2C5072Q26863277-50BF5B47-03B3-4A72-ABA9-5E205C1B7742Q27001931-A88E2B17-56C8-4C8A-9F96-5EC013315C95Q27009355-55960DCE-1360-4A70-83D1-86E61CEB7B9BQ28077688-FCE40B6A-ECCF-413E-911E-4F161141AC77Q28078467-EAE9D760-BD8C-43BC-80B0-F6187C72B132Q30613292-19888B5E-982F-4A36-8CA8-0EA7239C7A81Q31117218-65C33877-8B3C-4C21-A451-360FF50F25D6Q33514840-90AC3EEF-EFE6-477C-A84C-B78E34A41B96Q33585766-44B070B0-291F-4F97-94F2-3E6493AED0C4Q33591271-84C96510-03B7-470A-B509-755B1A83C00EQ33680901-28A5773B-150D-4210-B632-99D5DEA9810CQ33797616-D2189DF9-0922-4DE2-B0F5-192625119D25Q33871367-815B89BD-9894-42AE-8B7A-5BC029FB800CQ33871459-3B97A4D2-B291-440D-B635-35905DBB07C8Q33880174-2138DA6B-DA70-4816-9FD6-3FB073691AA3Q33919499-3D4D7686-D19E-4B90-8566-B84ED7348080Q34069238-8E1B3396-537B-461F-88CC-05074732EEF6Q34299641-3CE73320-4B18-47DB-B4B0-06E87A7AE22EQ34449820-A0F560F2-CE8F-4DC7-BF4F-975AF319D8F1Q34506998-E85753A7-F917-4109-895D-0A887FC97946Q34507342-9B7C4502-A5D6-4DC2-B50C-08BBBEC75B8EQ34540958-97340B44-D66D-47A4-B395-61D45913255DQ34540987-8EE5ECED-8771-4BD0-AA3F-659CBBE26D81Q34565168-681B2C49-3540-4981-96A3-7598311DF37FQ34581781-B60B670E-E1E1-4684-8D7F-3B323B22ED2FQ34620736-84FDFA0F-1D1E-4420-9CE6-55C791267190Q34622183-968612F2-769A-44DA-B9EA-008F1EAD1BD7Q34783357-E6BF412B-B385-4CB3-A33D-D689402917AAQ34829290-752FB072-2D45-4619-AC3D-774CFBA9233EQ34851203-5C32D467-9F6B-49BE-97B3-E475619B8573Q35073384-05E6C717-7B72-4829-9877-6412D7854915Q35529658-755BCE74-A0C3-45B0-8313-0BF3F709B0B7Q35647028-ED1A7906-5589-4CB1-9A6C-9FFBE3D1FDA4Q35673081-813A398D-B0E3-4DD0-9E37-3185F5367D77Q35772621-E9B64978-7CF8-46E5-9202-BB7330E697FCQ35894554-0167ECD0-3022-41F3-A019-77E7587FB02E
P2860
Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Initiating insulin therapy in ...... sic and basal insulin analogs.
@ast
Initiating insulin therapy in ...... sic and basal insulin analogs.
@en
type
label
Initiating insulin therapy in ...... sic and basal insulin analogs.
@ast
Initiating insulin therapy in ...... sic and basal insulin analogs.
@en
prefLabel
Initiating insulin therapy in ...... sic and basal insulin analogs.
@ast
Initiating insulin therapy in ...... sic and basal insulin analogs.
@en
P2093
P356
P1433
P1476
Initiating insulin therapy in ...... sic and basal insulin analogs.
@en
P2093
Alan Garber
Andrew Lewin
Bruce Bode
Elsie Allen
INITIATE Study Group
Philip Raskin
Priscilla Hollander
Robert A Gabbay
P304
P356
10.2337/DIACARE.28.2.260
P407
P577
2005-02-01T00:00:00Z